Literature DB >> 1921345

Death certificate categorization of malignant pleural and peritoneal mesothelioma in a cohort of asbestos insulation workers.

J Ribak1, R Lilis, Y Suzuki, L Penner, I J Selikoff.   

Abstract

Accuracy of diagnosis of malignant mesothelioma (pleural and peritoneal) was studied in a cohort of asbestos insulation workers in the United States and Canada. Initial clinical diagnosis, clinical diagnosis at death and death certificate diagnosis were compared with the diagnosis of malignant mesothelioma ascertained by full data review at the Division of Environmental and Occupational Medicine, Mount Sinai Medical Center, New York ('best evidence'). In both groups the death certificate diagnosis was somewhat less frequently accurate than clinical diagnosis at death. Knowledge of the patients' occupational history by the attending physician and its relation to accuracy of diagnosis of malignant mesothelioma is considered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921345     DOI: 10.1093/occmed/41.3.137

Source DB:  PubMed          Journal:  J Soc Occup Med        ISSN: 0301-0023


  4 in total

1.  Ill-defined and multiple causes on death certificates--a study of misclassification in mortality statistics.

Authors:  M D'Amico; E Agozzino; A Biagino; A Simonetti; P Marinelli
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

Review 2.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  Accuracy of death certification of pleural mesothelioma in Italy.

Authors:  C Bruno; P Comba; P Maiozzi; T Vetrugno
Journal:  Eur J Epidemiol       Date:  1996-08       Impact factor: 8.082

4.  Quantitative relationships of exposure to chrysotile asbestos and mesothelioma mortality.

Authors:  Dana Loomis; David B Richardson; Leslie Elliott
Journal:  Am J Ind Med       Date:  2019-05-13       Impact factor: 2.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.